Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.
about
Free fatty acid-induced PP2A hyperactivity selectively impairs hepatic insulin action on glucose metabolismPathway-selective insulin resistance and metabolic disease: the importance of nutrient fluxPancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the BlockThe islet circadian clock: entrainment mechanisms, function and role in glucose homeostasisParent-of-origin effects on glucose homeostasis in polycystic ovary syndrome.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Ingestion of a moderate high-sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon-like peptide-1 secretionLMNA Sequences of 60,706 Unrelated Individuals Reveal 132 Novel Missense Variants in A-Type Lamins and Suggest a Link between Variant p.G602S and Type 2 DiabetesA link between hepatic glucose production and peripheral energy metabolism via hepatokinesBaicalein Protects against Type 2 Diabetes via Promoting Islet β-Cell Function in Obese Diabetic Mice.Oral glucose tolerance test-based calculation identifies different glucose intolerance phenotypes within the impaired fasting glucose rangeQuantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolismElectrical vs manual acupuncture stimulation in a rat model of polycystic ovary syndrome: different effects on muscle and fat tissue insulin signaling.Central endocannabinoid signaling regulates hepatic glucose production and systemic lipolysisIncreased gluconeogenesis in youth with newly diagnosed type 2 diabetesDecreased expression of hepatic glucokinase in type 2 diabetes.Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice.Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-AnalysisPulsatile portal vein insulin delivery enhances hepatic insulin action and signaling.Transcriptional and Chromatin Regulation during Fasting - The Genomic EraSulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes.Direct renin inhibition modulates insulin resistance in caveolin-1-deficient miceVitamin E and vitamin C do not reduce insulin sensitivity but inhibit mitochondrial protein expression in exercising obese rats.Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1.Effects of 11β-hydroxysteroid dehydrogenase-1 inhibition on hepatic glycogenolysis and gluconeogenesis.Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.Activation of basal gluconeogenesis by coactivator p300 maintains hepatic glycogen storage.Mild fasting hyperglycemia shifts fuel reliance toward fat during exercise in adults with impaired glucose toleranceEffects of low-dose prednisolone on hepatic and peripheral insulin sensitivity, insulin secretion, and abdominal adiposity in patients with inflammatory rheumatologic disease.Pyrrolidine dithiocarbamate enhances hepatic glycogen synthesis and reduces FoxO1-mediated gene transcription in type 2 diabetic rats.Mechanisms of current therapies for diabetes mellitus type 2Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD-6972 in healthy subjects and subjects with type 2 diabetes mellitus.Naturally occurring variants of the dysglycemic peptide pancreastatin: differential potencies for multiple cellular functions and structure-function correlation.Regulation of hepatic energy metabolism and gluconeogenesis by BADTen questions about systems biology.Hormonal regulation of hepatic glucose production in health and disease.The role of dysregulated glucagon secretion in type 2 diabetes.Evidence against a physiologic role for acute changes in CNS insulin action in the rapid regulation of hepatic glucose production
P2860
Q24810354-949CC0F3-4E6B-4173-AB8F-7F49D3E621ACQ26820876-4B37282D-A769-4A71-A99A-ADB706D7DDF1Q26825393-9D874CBA-7110-499E-9F7D-E29CDE26D937Q26828996-3A6AA3FE-2235-41AF-95AC-62E78C300BE0Q30371644-F04376C2-8B5B-4849-9F1A-0536B8216366Q33569169-EA83D013-2308-4E34-8C6C-DEC605506EC3Q33603296-E17CC467-1730-49BB-BBBB-20193AF9F99DQ33799816-441A98B1-D57B-4ACA-B506-7BAE5F82D8F5Q33906438-BE73FE88-9F5C-4F4C-8C5C-EBF1C52D8696Q34043054-A91563FD-A4E5-4D8A-8BF4-5D739ABEBA2DQ34299634-3278D41E-9B3F-4E9A-9C48-19E204E505A6Q34325481-1293CA1E-6363-43EF-965D-9AD7572F59D2Q34562964-882F833B-0F62-4053-A040-FC862C0FA50BQ34718604-EE8B8963-09DA-4333-A8A3-B98C54093738Q35071262-690A7029-7AEF-46FA-B13C-A5A99CB47C6FQ35113468-CA952E97-86DB-401C-A4DF-EBBEC20582B4Q35601144-EFCFA845-3610-4DF4-AE75-279C4930CBD7Q35709954-E68FBE7B-0FDB-4657-A60A-692A8FD3F40EQ35762651-9ADF2A89-FC50-4D1F-BC82-A85AEDE8A8FFQ36011993-5B219E2A-0AFF-412A-9FFC-1546F7E5142DQ36182573-6A06AF29-9B50-4863-AFD2-EC2E4D2F5D90Q36355517-A1A5372E-C29F-407A-BBEB-413FB3BCE5C3Q36405748-0143B2DC-D3B6-4051-B33A-E6B51A4A26E9Q36456701-94A7C57D-BBC2-4719-8914-8FFC1279CE99Q36463561-2C011BF2-0EC6-4C18-87B3-1EDCF961CA1CQ36715658-00ECA8D6-C8AD-41AE-A201-D222E0D46773Q36763940-8BFB4F6A-B416-4EE1-B602-024BE951B427Q36867522-D4F33FE6-62DF-4D61-B65B-008F6D902AB3Q37050347-49B6D7EB-9E46-4447-BBE0-D1D5D1759291Q37054672-707C22EF-5111-425F-B6F1-580B2719CA04Q37106376-8786A65A-4239-4C9E-9683-D957C4CB70DDQ37175510-E268E737-A4BE-48D3-A7FD-A8BE136000CEQ37180829-DACD8C09-4691-40DC-900C-535740ABCBFDQ37561118-29488D03-50E1-4256-A013-ED33B3D92419Q37583609-691A4FC4-1A31-498C-B919-BB22A82F33B0Q37677904-C7DFB0E5-39E3-4FEE-AD15-E4D08E64CFF4Q37827645-31C36235-90B4-4808-A2A0-FD1D2142BB63Q37896899-C2FBA56B-A74A-4CD8-A200-F0A54DD8F642Q37913523-E1E83D44-AF2A-4F6E-B5E9-CD7CF4EDEE09Q38007633-393E93C7-55B5-4041-98B3-6E37DD33BA1D
P2860
Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pathogenesis of fasting and po ...... tes: implications for therapy.
@ast
Pathogenesis of fasting and po ...... tes: implications for therapy.
@en
Pathogenesis of fasting and po ...... tes: implications for therapy.
@nl
type
label
Pathogenesis of fasting and po ...... tes: implications for therapy.
@ast
Pathogenesis of fasting and po ...... tes: implications for therapy.
@en
Pathogenesis of fasting and po ...... tes: implications for therapy.
@nl
prefLabel
Pathogenesis of fasting and po ...... tes: implications for therapy.
@ast
Pathogenesis of fasting and po ...... tes: implications for therapy.
@en
Pathogenesis of fasting and po ...... tes: implications for therapy.
@nl
P2860
P921
P356
P1433
P1476
Pathogenesis of fasting and po ...... tes: implications for therapy.
@en
P2093
Robert A Rizza
P2860
P304
P356
10.2337/DB10-1032
P407
P577
2010-08-12T00:00:00Z